Allogene Therapeutics Inc (NASDAQ:ALLO)

32.74
Delayed Data
As of Sep 18
 +0.75 / +2.34%
Today’s Change
21.67
Today|||52-Week Range
35.55
+21.57%
Year-to-Date
No recent news for Allogene Therapeutics Inc.

Today’s Trading

Previous close31.99
Today’s open31.96
Day’s range31.57 - 32.94
Volume396,018
Average volume (3 months)418,309
Market cap$3.7B
Data as of 4:00pm ET, 09/18/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+73.32%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.24

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-1.45-1.79%
ONCESpark Therapeutics I...-0.29-0.28%
MORMorphoSys AG+0.01+0.03%
NKTRNektar Therapeutics-0.60-2.90%
Data as of 4:00pm ET, 09/18/2019

Financials

Next reporting dateNovember 27, 2019
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$211.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David D. Chang
Chief Financial Officer
Eric Schmidt
Corporate headquarters
South San Francisco, California

Forecasts